Search results
Investigating novel treatment options in systemic sclerosis
Medical Xpress· 2 days agoAutologous hematopoietic stem cell transplantation (aHSCT) for SSc has been proven the most...
CAR-T cell therapy to treat blood cancers unlikely to increase risk of secondary cancers
UPI· 3 days agoA study of more than 700 patients treated at Stanford University found that the risk of secondary...
Risk of secondary cancers after CAR-T cell therapy low, according to large study
Science Daily· 5 days agoIn November 2023, the FDA issued a warning about a risk of secondary cancers -- particularly blood cancers -- that may be associated with CAR-T cell therapy. The warning was ...
Novel gene-editing therapy continues to show positive results in sickle cell patients
Medical Xpress· 2 days agoThis innovative treatment modifies a patient's own blood-formingstem cells to correct the mutation...
Pilot Study in JNCCN Explores New Approach for Reducing Anxiety and Improving Quality of Life after ...
Morning Times· 5 days agoComprehensive Cancer Network highlights a promising approach for alleviating distress, enhancing quality of life, improving physical function, and reducing fatigue in patients with blood cancers ...
Postdoctoral positions at University of Pennsylvania - Philadelphia, Pennsylvania (US) job with...
Nature· 4 days agoPostdoctoral positions funded by NIH are for study of meiosis and spermatogonial stem cells using mouse models. Generous stipend and benefits.
Only 1 in 20 animal studies results in treatments approved for humans
United Press International via Yahoo News· 2 days ago"A similar pattern can be seen in other neurological...limited practical translation," the team...
Pilot Study in JNCCN Explores New Approach for Reducing Anxiety and Improving Quality of Life after ...
The Woonsocket Call· 5 days agoComprehensive Cancer Network highlights a promising approach for alleviating distress, enhancing quality of life, improving physical function, and reducing fatigue in patients with blood cancers ...
Vertex says Casgevy benefit extends to nearly five years in sickle cell disease
Clinical Trials Arena via Yahoo Finance· 2 days agoVertex said in a statement: “The efficacy results are consistent with the previously reported...
Researchers unveil impact of east Asian gene variant on type 2 diabetes risk
Medical Xpress· 2 days agoIt was earlier discovered that a variation in the PAX4 gene specifically predisposes East Asians to a higher risk of developing type 2 diabetes (T2D), increasing lifetime risk by up to 1.8 times ...